BREAKING

Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago

ADVERTISEMENT

GS

GSK

All GSK Content

3 articles, transcripts, and reports

GlaxoSmithKline plc (GSK) Q4 2022 Earnings Call Transcript

GlaxoSmithKline plc (NYSE: GSK) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Nick Stone — Head of Global Investor Relations Dame Emma Walmsley — Chief Executive Officer…

February 1, 202350 min read

GlaxoSmithKline plc (GSK) Q4 2021 Earnings Call Transcript

GlaxoSmithKline plc (NYSE: GSK) Q4 2021 earnings call dated Feb. 09, 2022 Corporate Participants: Nick Stone — Head of Global Investor Relations Dame Emma Walmsley — Chief Executive Officer…

February 9, 202276 min read

GlaxoSmithKline plc. (GSK) Q1 2021 Earnings Call Transcript

GlaxoSmithKline plc. ( LON: GSK) Q1 2021 earnings call dated Apr. 28, 2021 Corporate Participants: Iain Mackay — Chief Financial Officer Dame Emma Walmsley — Chief Executive Officer Luke…

April 28, 202168 min read